T4K (p.Thr4Lys) variant of SGCA (Alpha-sarcoglycan)
T4K (p.Thr4Lys) in SGCA (Alpha-sarcoglycan) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
T4K (p.Thr4Lys) variant details
- p.Thr4Lys
- NCI-TCGA Cosmic COSV5624
- cosmic curated COSV56248
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available